Works matching IS 10196439 AND DT 2022 AND VI 61 AND IP 3
Results: 14
Effect of duty cycles of tumor-treating fields on glioblastoma cells and normal brain organoids.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5397
- By:
- Publication type:
- Article
Targeting histone demethylases as a potential cancer therapy.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5393
- By:
- Publication type:
- Article
lncKRT16P6 promotes tongue squamous cell carcinoma progression by sponging miR-3180 and regulating GATAD2A expression.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5401
- By:
- Publication type:
- Article
GDNF regulates lipid metabolism and glioma growth through RET/ERK/HIF-1/SREBP-1.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG
- By:
- Publication type:
- Article
Cryptotanshinone suppresses tumorigenesis by inhibiting lipogenesis and promoting reactive oxygen species production in KRAS-activated pancreatic cancer cells.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5398
- By:
- Publication type:
- Article
HHLA2 promotes tumor progression by long non-coding RNA H19 in human gallbladder cancer.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5402
- By:
- Publication type:
- Article
METTL3 antagonizes 5-FU chemotherapy and confers drug resistance in colorectal carcinoma.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5396
- By:
- Publication type:
- Article
Long non-coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5400
- By:
- Publication type:
- Article
Molecular mechanism, regulation, and therapeutic targeting of the STAT3 signaling pathway in esophageal cancer (Review).
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5395
- By:
- Publication type:
- Article
Tumor suppressive functions of WNT5A in rhabdomyosarcoma.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5392
- By:
- Publication type:
- Article
Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5390
- By:
- Publication type:
- Article
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review).
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5391
- By:
- Publication type:
- Article
miR-802 inhibits the aggressive behaviors of non-small cell lung cancer cells by directly targeting FGFR1.
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5389
- By:
- Publication type:
- Article
Glioma-neuronal interactions in tumor progression: Mechanism, therapeutic strategies and perspectives (Review).
- Published in:
- International Journal of Oncology, 2022, v. 61, n. 3, p. N.PAG, doi. 10.3892/ijo.2022.5394
- By:
- Publication type:
- Article